LabVantage Solutions, a provider of laboratory informatics solutions and services, announced that the United States Army Medical Research Acquisition Activity (USAMRAA) has awarded the company a contract to supply its LabVantage Pharma laboratory information management system (LIMS) to the Walter Reed Army Institute of Research (WRAIR), according to a press release.
WRAIR will use LabVantage Pharma to support vaccine production programs for COVID-19 and other diseases at its Pilot Bioproduction Facility.
LabVantage Pharma is based on LabVantage 8, a web-based, enterprise LIMS. LabVantage Pharma provides a complete package for pharmaceutical and biotech laboratories. It includes everything needed to get the LIMS up and running quickly, providing out-of-the box workflows and functionality needed to manage pharmaceutical manufacturing, including batch management, stability testing, consumables management, environmental monitoring, barcode label printing, and instrument calibration, certification and maintenance.
LabVantage Pharma is pre-validated according to GAMP 5 guidelines, which shortens the implementation process and reduces overall cost and risk. It complies with Title 21 CFR Part 11 regulatory requirements and is developed, tested, and maintained using a quality system based on IEEE standards for software quality. LabVantage Pharma facilitates the ability of laboratory administrators to manage the sample lifecycle, optimize laboratory execution, perform data retrieval, interface instruments and systems, and enable security and auditing.
